PharmaSUG2021paper·US·Real World Evidence and Big DataGenerating FDA-ready Submission Datasets directly from EHRs RW-063See metadata
PharmaSUG2021paper·US·Real World Evidence and Big DataA Programmer’s Experience Researching Real-World Evidence (RWE) COVID-19 Data RW-126See metadata
PharmaSUG2021paper·US·Real World Evidence and Big DataPatient Registries – New Gold Standard for Real World Data RW-160See metadata
PharmaSUG2021paper·US·Real World Evidence and Big DataBetter to Be Mocked Than Half-Cocked: Data Mocking Methods to Support Functional and Performance Testing of SAS Software RW-198See metadata
PharmaSUG2021paper·US·Real World Evidence and Big DataNHANES Dietary Supplement component: a parallel programming project RW-202See metadata
PharmaSUG2021paper·US·Real World Evidence and Big DataLife After Drug Approval… What Programmers Need to Know About REMS RW-208See metadata
PharmaSUG2021paper·US·Real World Evidence and Big DataStandardizing Laboratory Data From Diverse RWD to Enable Meaningful Assessments of Drug Safety and Effectiveness RW-209See metadata
PharmaSUG2021paper·China·Statistics & RA novel insight into confirmed Best Overall Response per RECIST 1.1 SR-038 ShanghaiSee metadata
PharmaSUG2021paper·China·Statistics & RNumber of Events Estimation using R step by step SR-041 ShanghaiSee metadata
PharmaSUG2021paper·China·Statistics & RBeing Therapeutic Area Coach for Programmers: Taking RECIST 1.1 Training as An Example SR-052 ShanghaiSee metadata
PharmaSUG2021paper·China·Statistics & RStatistical considerations in a case study disrupted by COVID-19 pandemic SR-055 ShanghaiSee metadata
PharmaSUG2021paper·China·Statistics & RBIP: A Powerful Biomarker Interactive Profiler based on R Shiny APP SR-057 ShanghaiSee metadata
PharmaSUG2021paper·China·Statistics & RBRAT: An R-Shiny Application on Block Randomization Allocation Process for Animal Experiments in Clinical Research Area SR-066 ShanghaiSee metadata
PharmaSUG2021paper·China·Statistics & RThe Application of Reference-Scaled Average Bioequivalence in Bioequivalence Analysis with Highly Variable Drug SR-078 ShanghaiSee metadata
PharmaSUG2021paper·China·Statistics & RInteractive web widgets and applications in R SR-079 ShanghaiSee metadata
PharmaSUG2021paper·US·Statistics and AnalyticsBack to Basics: Running an Analysis from Data to Refinement in SAS SA-032See metadata
PharmaSUG2021paper·US·Statistics and AnalyticsVisualization of Sparse PK Concentration Sampling Data, Step by Step (Improvement by Improvement) SA-043See metadata
PharmaSUG2021paper·US·Statistics and AnalyticsBuild a model: Introducing a methodology to develop multiple regression models using R in oncology trial analyses SA-047See metadata